Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon May 27, 2021 10:32am
64 Views
Post# 33275190

RE:LOI Carr

RE:LOI Carr
brad129 wrote: Not sure how this works, due to the magnitude of SP drop could that deal now be adjusted to reflect valuation? More share dilution?



I understood this to be a 15 million share deal with another 8 million possibly for achievement milestones post purchase regardless of sp - idea being that the actual sp is not a consideration, rather the 15 mil is the purchase price in itself.  Perhaps that 8 million shares post purchase  clause is a means of addressing a dramatic sp fall between time of discussion and actual closing date (which is the actual case here). In other words it may be a built in protection for CARE to ensure they receive a price somewhat closer to what it was when all of this was being negotiated.
<< Previous
Bullboard Posts
Next >>